NealJainMDFAAAAI, FACAAI, FAAP

PubMed

• 96 citations
  Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
  Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon
  The New England Journal of Medicine. 2021-12-09
• 30 citations
  Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
  Warner W. Carr, Neal Jain, J. Wesley Sublett
  Advances in Therapy. 2021-09-13
• 66 citations
  A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency.
  Eduardo López-Granados, Jeffrey E. Keenan, Matthew C. Kinney, Harvey L. Leo, Neal Jain
  Human Mutation. 2008-06-01

Journal Articles

• Correspondence: Should exhaled nitric oxide be part of routine asthma management.  
  Jain N, Boggs P, Zitt M, Ann Allergy Asthma Immunol, 1/1/2013
• A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency.  
  Lopez-Granados E, Keenan JE, Kinney MC, Leo H, Jain N, Ma CA, Quinones R, Gelfand EW, Jain A, Human Mutation, 1/1/2008
• Effect of Montelukast on Peripheral Airflow Obstruction in Children with Asthma.  
  Spahn JD, Covar RA, Jain N, Gleason M, Szefler SJ, Gelfand EW, Annals of Allergy, Asthma and Immunology, 1/1/2006
• Quantitative Computed Tomography Detects Peripheral Airway Disease in Asthmatic Children.  
  Jain N, Gleason M, Covar R, Newell JD, Gelfand EW, Spahn JD, Pediatric Pulmonology, 1/1/2005
• Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002.  
  Paull K, Covar RA, Jain N, Szefler SJ, Gelfand EW, Spahn JD, Pediatric Pulmonology, 1/1/2005
• Quantitative High Resolution CT Demonstrates Evidence for Peripheral Airway Disease in Asthmatic Children with Normal FEV1.  
  Jain N, Gleason M, Covar R, Newell JD, Gelfand EW, Spahn JD, J Allergy Clin Immunol, 1/1/2004
• New Concepts in the Pathogenesis of Atopic Dermatitis.  
  Jain N, Leo H, Leung DY, Current Opinion in Immunology, 1/1/2003
• Join now to see all

Abstracts/Posters

• Meta Analysis of Asthma Exacerbation Rates During Asthma Managed Using Fractional Exhaled Nitric Oxide Versus Standard Clinical Parameters Alone.
  Jain N, Dorinsky P, Donahue J, American College of Allergy Asthma and Immunology 2012 Annual Conference, Orlando, Florida., 1/1/2012
• Quantitative High Resolution CT Demonstrates Evidence for Peripheral Airway Disease in Asthmatic Children with Normal FEV1.
  Jain N, Gleason M, Covar R, Newell JD, Gelfand EW, Spahn JD, AAAAI 2004 national meeting in San Francisco, CA., 1/1/2004
• Foramen of Morgagni Hernia as the Cause of Recurrent Respiratory Complaints in a 17 year-old Previously Diagnosed with Severe Asthma.
  Jain N, Boguniewicz M, Larsen GL, Hay TC, ACAAI 2003 meeting, New Orleans, LA., 1/1/2003
• Lemierre’s Disease Presenting as Septic Arthritis.
  Jain N, Annual “Academic Excellence Day” Compilation of Abstracts., 1/1/1999
• Join now to see all

Lectures

• Lemierre’s Disease Presenting as Septic Arthritis. 
  “Academic Excellence Day”, Maricopa medical Center, Phoenix, AZ - 1/1/1999

Other

• AAAAI/ACAAI Joint Statement of Support of the ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide for Clinical Applications. 
  Zitt M, Oppehneimer J, Bernstein D, Boggs P, Dinakar C, Jain N, Katial R, Sands M, Szefler S
  http://www.acaai.org/Documents/FeNOJointStatement3-6-12.pdf.
  4/23/2012